ACAD icon

Acadia Pharmaceuticals

245 hedge funds and large institutions have $2.12B invested in Acadia Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 69 increasing their positions, 88 reducing their positions, and 47 closing their positions.

Holders
245
Holders Change
-17
Holders Change %
-6.49%
% of All Funds
4.14%
Holding in Top 10
2
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-66.67%
% of All Funds
0.03%
New
36
Increased
69
Reduced
88
Closed
47
Calls
$25.3M
Puts
$17.4M
Net Calls
+$7.88M
Net Calls Change
-$10.4M
Name Market Value Shares Shares
Change
Shares
Change %
CCP
276
Corient Capital Partners
California
-8,542 Closed
WP
277
WMS Partners
Maryland
-8,500 Closed
SS
278
Sunbelt Securities
Texas
-8,231 Closed
IC
279
Ikarian Capital
Texas
-1,882 Closed
MAM
280
McCarthy Asset Management
California
-1,666 Closed
ACM
281
Aquatic Capital Management
Illinois
-1,400 Closed
QC
282
Quent Capital
New York
-796 Closed
UB
283
UMB Bank
Missouri
-794 Closed
TWA
284
TCI Wealth Advisors
Arizona
-564 Closed
FAG
285
Fortitude Advisory Group
Washington
-215 Closed
Bessemer Group
286
Bessemer Group
New Jersey
-191 Closed
C
287
Covestor
United Kingdom
$0 19 -143 -88%
TF
288
TimeScale Financial
Massachusetts
-100 Closed
Kayne Anderson Rudnick Investment Management
289
Kayne Anderson Rudnick Investment Management
California
-55 Closed
T
290
TCWP
Ohio
-32 Closed
Nomura Asset Management
291
Nomura Asset Management
Japan
PVI
292
Pura Vida Investments
New York
JGC
293
J. Goldman & Co
New York
TMC
294
Trellus Management Company
Florida
CAC
295
Cowen and Company
New York
OIA
296
Optimum Investment Advisors
Illinois
BTI
297
Blue Trust Inc
Georgia
$0 12 +12 New
BIA
298
Bell Investment Advisors
California
$0 29 +29 New